{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:15:29Z","timestamp":1780758929327,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000774","name":"Newcastle University","doi-asserted-by":"publisher","award":["MR\/K02325X\/1"],"award-info":[{"award-number":["MR\/K02325X\/1"]}],"id":[{"id":"10.13039\/501100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12969-018-0231-3","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T04:10:58Z","timestamp":1519963858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list"],"prefix":"10.1186","volume":"16","author":[{"given":"Fabian","family":"Speth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claas H.","family":"Hinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Andel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes-Peter","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,2]]},"reference":[{"key":"231_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2431-11-31","volume":"11","author":"V Wiegering","year":"2011","unstructured":"Wiegering V, Schick J, Beer M, Weissbrich B, Gattenlohner S, Girschick HJ, Liese J, Schlegel PG, Eyrich M. Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis. BMC pediatrics. 2011;11:31.","journal-title":"BMC pediatrics"},{"issue":"2","key":"231_CR2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1542\/peds.65.2.346","volume":"65","author":"K Ha","year":"1980","unstructured":"Ha K, Baba K, Ikeda T, Nishida M, Yabuuchi H, Takahashi M. Application of live varicella vaccine to children with acute leukemia or other malignancies without suspension of anticancer therapy. Pediatrics. 1980;65(2):346\u201350.","journal-title":"Pediatrics"},{"issue":"4 Pt 2","key":"231_CR3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1542\/peds.78.4.736","volume":"78","author":"M Takahashi","year":"1986","unstructured":"Takahashi M. Clinical overview of varicella vaccine: development and early studies. Pediatrics. 1986;78(4 Pt 2):736\u201341.","journal-title":"Pediatrics"},{"issue":"2","key":"231_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1399-3046.2005.00279.x","volume":"9","author":"S Chaves Tdo","year":"2005","unstructured":"Chaves Tdo S, Lopes MH, de Souza VA, Dos Santos SS, Pereira LM, Reis AD, David-Neto E. Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients. Pediatr. Transplant. 2005;9(2):192\u20136.","journal-title":"Pediatr. Transplant"},{"issue":"2","key":"231_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1067\/mpd.2003.37","volume":"142","author":"SL Furth","year":"2003","unstructured":"Furth SL, Arbus GS, Hogg R, Tarver J, Chan C, Fivush BA. Southwest Pediatric Nephrology Study G: Varicella vaccination in children with nephrotic syndrome: a report of the Southwest Pediatric Nephrology Study Group. J. Pediatr. 2003;142(2):145\u20138.","journal-title":"J. Pediatr"},{"issue":"4 Pt 2","key":"231_CR6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1542\/peds.78.4.757","volume":"78","author":"AA Gershon","year":"1986","unstructured":"Gershon AA, Steinberg SP, Gelb L. Live attenuated varicella vaccine use in immunocompromised children and adults. Pediatrics. 1986;78(4 Pt 2):757\u201362.","journal-title":"Pediatrics"},{"issue":"4","key":"231_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00007890-200208270-00020","volume":"74","author":"H Kano","year":"2002","unstructured":"Kano H, Mizuta K, Sakakihara Y, Kato H, Miki Y, Shibuya N, Saito M, Narita M, Kawarasaki H, Igarashi T, et al. Efficacy and safety of immunization for pre- and post- liver transplant children. Transplantation. 2002;74(4):543\u201350.","journal-title":"Transplantation"},{"issue":"5","key":"231_CR8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MPG.0b013e3181bab351","volume":"50","author":"Y Lu","year":"2010","unstructured":"Lu Y, Bousvaros A. Varicella vaccination in children with inflammatory bowel disease receiving immunosuppressive therapy. J. Pediatr. Gastroenterol. Nutr. 2010;50(5):562\u20135.","journal-title":"J. Pediatr. Gastroenterol. Nutr"},{"issue":"3","key":"231_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1600-6143.2005.01210.x","volume":"6","author":"A Weinberg","year":"2006","unstructured":"Weinberg A, Horslen SP, Kaufman SS, Jesser R, Devoll-Zabrocki A, Fleckten BL, Kochanowicz S, Seipel KR, Levin MJ. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2006;6(3):565\u20138.","journal-title":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"2","key":"231_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/BF00865476","volume":"8","author":"I Zamora","year":"1994","unstructured":"Zamora I, Simon JM, Da Silva ME, Piqueras AI. Attenuated varicella virus vaccine in children with renal transplants. Pediatr. Nephrol. 1994;8(2):190\u20132.","journal-title":"Pediatr. Nephrol"},{"issue":"8","key":"231_CR11","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/00006454-200008000-00022","volume":"19","author":"F Ghaffar","year":"2000","unstructured":"Ghaffar F, Carrick K, Rogers BB, Margraf LR, Krisher K, Ramilo O. Disseminated infection with varicella-zoster virus vaccine strain presenting as hepatitis in a child with adenosine deaminase deficiency. Pediatr. Infect. Dis. J. 2000;19(8):764\u20136.","journal-title":"Pediatr. Infect. Dis. J"},{"issue":"2","key":"231_CR12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.2.e39","volume":"108","author":"JM Kramer","year":"2001","unstructured":"Kramer JM, LaRussa P, Tsai WC, Carney P, Leber SM, Gahagan S, Steinberg S, Blackwood RA. Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child. Pediatrics. 2001;108(2):E39.","journal-title":"Pediatrics"},{"issue":"3","key":"231_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0891-5520(05)70314-7","volume":"10","author":"AA Gershon","year":"1996","unstructured":"Gershon AA, LaRussa P, Steinberg S. The varicella vaccine. Clinical trials in immunocompromised individuals. Infectious disease clinics of North America. 1996;10(3):583\u201394.","journal-title":"Infectious disease clinics of North America"},{"issue":"5","key":"231_CR14","first-page":"791","volume":"30","author":"CM Barbosa","year":"2012","unstructured":"Barbosa CM, Terreri MT, Rosario PO, de Moraes-Pinto MI, Silva CA, Hilario MO. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus. Clin. Exp. Rheumatol. 2012;30(5):791\u20138.","journal-title":"Clin. Exp. Rheumatol"},{"issue":"7","key":"231_CR15","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/acr.20183","volume":"62","author":"GS Pileggi","year":"2010","unstructured":"Pileggi GS, de Souza CB, Ferriani VP. Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids. Arthritis care & research. 2010;62(7):1034\u20139.","journal-title":"Arthritis care & research"},{"issue":"33","key":"231_CR16","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1016\/j.vaccine.2015.06.086","volume":"33","author":"N Toplak","year":"2015","unstructured":"Toplak N, Avcin T. Long-term safety and efficacy of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy. Vaccine. 2015;33(33):4056\u20139.","journal-title":"Vaccine"},{"issue":"1","key":"231_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1542\/peds.99.1.35","volume":"99","author":"M Broyer","year":"1997","unstructured":"Broyer M, Tete MJ, Guest G, Gagnadoux MF, Rouzioux C. Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics. 1997;99(1):35\u20139.","journal-title":"Pediatrics"},{"issue":"3","key":"231_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/clinids\/17.3.441","volume":"17","author":"IC Kitai","year":"1993","unstructured":"Kitai IC, King S, Gafni A. An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1993;17(3):441\u20137.","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"Suppl 2","key":"231_CR19","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1086\/522133","volume":"197","author":"MJ Levin","year":"2008","unstructured":"Levin MJ. Varicella vaccination of immunocompromised children. Am. J. Infect. Dis. 2008;197(Suppl 2):S200\u20136.","journal-title":"Am. J. Infect. Dis"},{"issue":"5","key":"231_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijid.2003.09.006","volume":"8","author":"AM Sartori","year":"2004","unstructured":"Sartori AM. A review of the varicella vaccine in immunocompromised individuals. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2004;8(5):259\u201370.","journal-title":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases"},{"issue":"10","key":"231_CR21","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/ard.2011.150193","volume":"70","author":"MW Heijstek","year":"2011","unstructured":"Heijstek MW, Ott de Bruin LM, Bijl M, Borrow R, van der Klis F, Kone-Paut I, Fasth A, Minden K, Ravelli A, Abinun M, et al. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann. Rheum. Dis. 2011;70(10):1704\u201312.","journal-title":"Ann. Rheum. Dis"},{"issue":"11","key":"231_CR22","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E, Childhood A, Rheumatology Research A. Pediatric Rheumatology International Trials O, Pediatric Rheumatology Collaborative Study G: Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J. Rheumatol. 2004;31(11):2290\u20134.","journal-title":"J. Rheumatol"},{"issue":"3","key":"231_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/cid\/cit816","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014;58(3):309\u201318.","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"4","key":"231_CR24","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/eji.200940017","volume":"40","author":"G Di Genova","year":"2010","unstructured":"Di Genova G, Savelyeva N, Suchacki A, Thirdborough SM, Stevenson FK. Bystander stimulation of activated CD4+ T cells of unrelated specificity following a booster vaccination with tetanus toxoid. Eur. J. Immunol. 2010;40(4):976\u201385.","journal-title":"Eur. J. Immunol"},{"issue":"5","key":"231_CR25","doi-asserted-by":"publisher","first-page":"R171","DOI":"10.1186\/ar4358","volume":"15","author":"M Crnkic Kapetanovic","year":"2013","unstructured":"Crnkic Kapetanovic M, Saxne T, Jonsson G, Truedsson L, Geborek P. Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis. Arthritis research & therapy. 2013;15(5):R171.","journal-title":"Arthritis research & therapy"},{"issue":"3","key":"231_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/acr.21838","volume":"65","author":"AC Ribeiro","year":"2013","unstructured":"Ribeiro AC, Laurindo IM, Guedes LK, Saad CG, Moraes JC, Silva CA, Bonfa E. Abatacept and reduced immune response to pandemic 2009 influenza A\/H1N1 vaccination in patients with rheumatoid arthritis. Arthritis care & research. 2013;65(3):476\u201380.","journal-title":"Arthritis care & research"},{"issue":"5","key":"231_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.4103\/1319-2442.164556","volume":"26","author":"R Karbasi-Afshar","year":"2015","unstructured":"Karbasi-Afshar R, Izadi M, Fazel M, Khedmat H. Response of transplant recipients to influenza vaccination based on type of immunosuppression: A meta-analysis. Saudi J Kidney Dis Transpl. 2015;26(5):877\u201383.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"22","key":"231_CR28","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","volume":"325","author":"I Hardy","year":"1991","unstructured":"Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N. Engl. J. Med. 1991;325(22):1545\u201350.","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"231_CR29","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/infdis\/162.5.1049","volume":"162","author":"RE Bergen","year":"1990","unstructured":"Bergen RE, Diaz PS, Arvin AM. The immunogenicity of the Oka\/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content. J. Infect. Dis. 1990;162(5):1049\u201354.","journal-title":"J. Infect. Dis"},{"issue":"2","key":"231_CR30","doi-asserted-by":"crossref","first-page":"636","DOI":"10.4049\/jimmunol.142.2.636","volume":"142","author":"PS Diaz","year":"1989","unstructured":"Diaz PS, Smith S, Hunter E, Arvin AM. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. J. Immunol. 1989;142(2):636\u201341.","journal-title":"J. Immunol"},{"issue":"5","key":"231_CR31","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/clinids\/24.5.753","volume":"24","author":"CJ White","year":"1997","unstructured":"White CJ. Varicella-zoster virus vaccine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1997;24(5):753\u201361. quiz 762-753","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"1","key":"231_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1365-2249.1994.tb06618.x","volume":"98","author":"Y Zhang","year":"1994","unstructured":"Zhang Y, Cosyns M, Levin MJ, Hayward AR. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin. Exp. Immunol. 1994;98(1):128\u201333.","journal-title":"Clin. Exp. Immunol"},{"key":"231_CR33","first-page":"421","volume":"49","author":"R Koch-Institut","year":"2004","unstructured":"Koch-Institut R. Begr\u00fcndung der STIKO f\u00fcr eine allgemeine Varizellenimpfung. Epidemiologisches Bulletin. 2004;49:421\u20133.","journal-title":"Epidemiologisches Bulletin"},{"key":"231_CR34","first-page":"328","volume":"49","author":"R Koch-Institut","year":"2009","unstructured":"Koch-Institut R. Impfung gegen Varizellen im Kindesalter: Empfehlung einer zweiten Varizellenimpfung Empfehlung und Begr\u00fcndung. Epidemiologisches Bulletin. 2009;49:328\u201336.","journal-title":"Epidemiologisches Bulletin"},{"key":"231_CR35","unstructured":"WHO vaccine-preventable diseases: monitoring system. 2017 global summary [ http:\/\/apps.who.int\/immunization_monitoring\/globalsummary ]"},{"key":"231_CR36","unstructured":"Control ECfDPa: Varicella vaccination in the European Union. 2015."},{"issue":"Suppl 2","key":"231_CR37","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.1086\/522157","volume":"197","author":"KK Macartney","year":"2008","unstructured":"Macartney KK, Burgess MA. Varicella vaccination in Australia and New Zealand. J. Infect. Dis. 2008;197(Suppl 2):S191\u20135.","journal-title":"J. Infect. Dis"},{"issue":"3","key":"231_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/art.1780180309","volume":"18","author":"DB Sullivan","year":"1975","unstructured":"Sullivan DB, Cassidy JT, Petty RE. Pathogenic implications of age of onset in juvenile rheumatoid arthritis. Arthritis and rheumatism. 1975;18(3):251\u20135.","journal-title":"Arthritis and rheumatism"},{"issue":"2","key":"231_CR39","doi-asserted-by":"publisher","first-page":"476","DOI":"10.4161\/hv.26986","volume":"10","author":"T Rieck","year":"2014","unstructured":"Rieck T, Feig M, Eckmanns T, Benzler J, Siedler A, Wichmann O. Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Human vaccines & immunotherapeutics. 2014;10(2):476\u201384.","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"4","key":"231_CR40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1542\/peds.80.4.465","volume":"80","author":"S Feldman","year":"1987","unstructured":"Feldman S, Lott L. Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics. 1987;80(4):465\u201372.","journal-title":"Pediatrics"},{"issue":"3","key":"231_CR41","first-page":"135","volume":"23","author":"T Kumagai","year":"1980","unstructured":"Kumagai T, Chiba Y, Fujiwara M, Hanazono H, Nakamura S, Chiba S, Nakao T, Takahashi M. Humoral and cellular immune response to varicella-zoster virus in children inoculated with live attenuated varicella vaccine. Biken journal. 1980;23(3):135\u201341.","journal-title":"Biken journal"},{"key":"231_CR42","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices Centers for Disease C, Prevention: Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports:Morbidity and mortality weekly report Recommendations and reports\/Centers for Disease Control 2008, 57(RR-5):1-30; quiz CE32-34."},{"issue":"8","key":"231_CR43","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/art.23112","volume":"57","author":"AL Smitten","year":"2007","unstructured":"Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis and rheumatism. 2007;57(8):1431\u20138.","journal-title":"Arthritis and rheumatism"},{"key":"231_CR44","first-page":"93","volume":"10","author":"AA Gershon","year":"1995","unstructured":"Gershon AA. Varicella-zoster virus: prospects for control. Advances in pediatric infectious diseases. 1995;10:93\u2013124.","journal-title":"Advances in pediatric infectious diseases"},{"issue":"1","key":"231_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1046\/j.1442-200X.1999.t01-1-01015.x","volume":"41","author":"K Oitani","year":"1999","unstructured":"Oitani K. Expression of interleukin-2 receptor, CD25, on CD4 lymphocytes in response to varicella-zoster virus antigen among patients with malignancies immunized with live attenuated varicella vaccine. Pediatrics international : official journal of the Japan Pediatric Society. 1999;41(1):32\u20136.","journal-title":"Pediatrics international : official journal of the Japan Pediatric Society"},{"key":"231_CR46","doi-asserted-by":"crossref","unstructured":"Speth F, Haas JP, Kneitz C, Warnatz K, Minden K: [Vaccinations in immunosuppressed young rheumatics in transition]. arthritis + rheuma 2017, 37(1):39-58.","DOI":"10.1055\/s-0037-1618409"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0231-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T11:14:11Z","timestamp":1693566851000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-018-0231-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["231"],"URL":"https:\/\/doi.org\/10.1186\/s12969-018-0231-3","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,2]]},"assertion":[{"value":"8 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Declaration of Helsinki. The study was approved by the Institutional Board of Ethics in Medical Research of the Bavarian Chamber of Physicians. Written informed consent was obtained from all parents and the patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Individual patients and their parents consented to publication of their data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Mertens currently became the director of the German Standing Committee on Vaccinations (\u201cSt\u00e4ndige Impfkommission\u201d; STIKO). The other authors have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"15"}}